References
- Aliannejad R, Saburi A, Ghanei M. (2013). Cardiopulmonary exercise test findings in symptomatic mustard gas exposed cases with normal HRCT. Pulm Circ 3:414–18.
- Black AT, Joseph LB, Casillas RP, et al. (2010). Role of MAP kinases in regulating expression of antioxidants and inflammatory mediators in mouse keratinocytes following exposure to the half mustard, 2-chloroethyl ethyl sulfide. Toxicol Appl Pharm 245:352–60.
- Brimfield A, Mancebo A, Mason R, et al. (2009). Free radical production from the interaction of 2-chloroethyl vesicants (mustard gas) with pyridine nucleotide-driven flavoprotein electron transport systems. Toxicol Appl Pharm 234:128–34.
- Brown FF, Campbell ID, Kuchel PW, Rabenstein DC. (1977). Human erythrocyte metabolism studies by 1H spin echo NMR. FEBS Lett 82:12–16.
- Council U. (1986). Report of the mission dispatched by the Secretary-General to investigate allegations of the use of chemical weapons in the conflict between the Islamic Republic of Iran and Iraq. Geneva: United Nations Security Council.
- Eilers PH. (2004). Parametric time warping. Anal Chem 76:404–11.
- Fardet A, Canlet C, Gottardi G, et al. (2007). Whole-grain and refined wheat flours show distinct metabolic profiles in rats as assessed by a 1H NMR-based metabonomic approach. J Nutr 137:923–9.
- Fathi F, Kasmaee LM, Sohrabzadeh K, et al. (2014a). The differential diagnosis of Crohn’s disease and celiac disease using nuclear magnetic resonance spectroscopy. Appl Magn Reson 45:451–9.
- Fathi F, Majari-Kasmaee L, Mani-Varnosfaderani A, et al. (2014b). NMR based metabolic profiling in Crohn's disease by random forest methodology. Magn Reson Chem 52:370–6. 6.
- Fedeles BI, Zhu AY, Young KS, et al. (2011). Chemical genetics analysis of an aniline mustard anticancer agent reveals complex I of the electron transport chain as a target. J Biol Chem 286:33910–20.
- Freitag L, Firusian N, Stamatis G, Greschuchna D. (1991). The role of bronchoscopy in pulmonary complications due to mustard gas inhalation. Chest J 100:1436–41.
- Gautam A, Vijayaraghavan R, Sharma M, Ganesan K. (2006). Comparative toxicity studies of sulfur mustard (2, 2′-dichloro diethyl sulfide) and monofunctional sulfur mustard (2-chloroethyl ethyl sulfide), administered through various routes in mice. J Med CBR Def 4:1–21.
- Gentilhomme E, Neveux Y, Hua A, et al. (1992). Action of bis (betachloroethyl) sulphide (BCES) on human epidermis reconstituted in culture: morphological alterations and biochemical depletion of glutathione. Toxicol In Vitro 6:139–47.
- Ghanei M, Tazelaar HD, Chilosi M, et al. (2008). An international collaborative pathologic study of surgical lung biopsies from mustard gas-exposed patients. Respir Med 102:825–30.
- Gould NS, White CW, Day BJ. (2009). A role for mitochondrial oxidative stress in sulfur mustard analog 2-chloroethyl ethyl sulfide-induced lung cell injury and antioxidant protection. J Pharmacol Exp Ther 328:732–9.
- Heller A, Koch T, Schmeck J, van Ackern K. (1998). Lipid mediators in inflammatory disorders. Drugs 55:487–96.
- Khateri S, Ghanei M, Keshavarz S, et al. (2003). Incidence of lung, eye, and skin lesions as late complications in 34,000 Iranians with wartime exposure to mustard agent. J Occup Environ Med 45:1136–43.
- Kugaya A, Sanacora G. (2005). Beyond monoamines: glutamatergic function in mood disorders. CNS Spectr 10:808–19.
- Lindgren F, Hansen B, Karcher W, et al. (1996). Model validation by permutation tests: applications to variable selection. J Chemometr 10:521–32.
- Mahadevan S, Shah SL, Marrie TJ, Slupsky CM. (2008). Analysis of metabolomic data using support vector machines. Anal Chem 80:7562–70.
- Mitchell G, Kassovska-Bratinova S, Boukaftane Y, et al. (1995). Medical aspects of ketone body metabolism. Clin Invest Med 18:193–216.
- Moroni F. (1999). Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites. Eur J Pharmacol 375:87–100.
- Nicholson JK, Lindon JC. (2008). Systems biology: metabonomics. Nature 455:1054–6.
- Nielsen NPV, Carstensen JM, Smedsgaard J. (1998). Aligning of single and multiple wavelength chromatographic profiles for chemometric data analysis using correlation optimised warping. J Chromatogr 805:17–35.
- Nobakht M, Gh BF, Aliannejad R, et al. (2014). The metabolomics of airway diseases, including COPD, asthma and cystic fibrosis. Biomarkers 20:5–16.
- Nobakht M, Gh BF, Oskouie AA, et al. (2015). Pro-oxidant–antioxidant balance in Iranian veterans with sulfur mustard toxicity and different levels of pulmonary disorders. Drug Chem Toxicol. [Epub ahead of print]. DOI:10.3109/01480545.2015.1122033.
- Palucha A, Pilc A. (2005). The involvement of glutamate in the pathophysiology of depression. Drug News Perspect 18:262–8.
- Renshaw B. (1946). Mechanisms in production of cutaneous injuries by sulfur and nitrogen mustards. In: Chemical warfare agents, and related chemical problems Parts III–IV. National Defense Research Committee of the Office of Scientific Research and Development, Washington (DC): Defense Technical Information Center Access Documents. 249: 479–518.
- Robroeks CM, van Berkel JJ, Dallinga JW, et al. (2010). Metabolomics of volatile organic compounds in cystic fibrosis patients and controls. Pediatr Res 68:75–80.
- Rodríguez DA, Alcarraz-Vizán G, Díaz-Moralli S, et al. (2012). Plasma metabolic profile in COPD patients: effects of exercise and endurance training. Metabolomics 8:508–16.
- Saude EJ, Skappak CD, Regush S, et al. (2011). Metabolomic profiling of asthma: diagnostic utility of urine nuclear magnetic resonance spectroscopy. J Allergy Clin Immunol 127:757–64.
- Shahin S, Cullinane C, Gray PJ. (2001). Mitochondrial and nuclear DNA damage induced by sulphur mustard in keratinocytes. Chem Biol Interact 138:231–45.
- Shockcor JP, Holmes E. (2002). Metabonomic applications in toxicity screening and disease diagnosis. Curr Top Med Chem 2:35–51.
- Shohrati M, Ghanei M, Shamspour N, et al. (2010). Glutathione and malondialdehyde levels in late pulmonary complications of sulfur mustard intoxication. Lung 188:77–83.
- Skov T, van den Berg F, Tomasi G, Bro R. (2006). Automated alignment of chromatographic data. J Chemometr 20:484–97.
- Sourdeval M, Lemaire C, Deniaud A, et al. (2006). Inhibition of caspase-dependent mitochondrial permeability transition protects airway epithelial cells against mustard-induced apoptosis. Apoptosis 11:1545–59.
- Tang H, Wang Y, Nicholson JK, Lindon JC. (2004). Use of relaxation-edited one-dimensional and two dimensional nuclear magnetic resonance spectroscopy to improve detection of small metabolites in blood plasma. Anal Biochem 325:260–72.
- Tomasi G, van den Berg F, Andersson C. (2004). Correlation optimized warping and dynamic time warping as preprocessing methods for chromatographic data. J Chemometr 18:231–41.
- Ubhi BK, Cheng KK, Dong J, et al. (2012a). Targeted metabolomics identifies perturbations in amino acid metabolism that sub-classify patients with COPD. Mol BioSyst 8:3125–33.
- Ubhi BK, Riley JH, Shaw PA, et al. (2012b). Metabolic profiling detects biomarkers of protein degradation in COPD patients. Eur Respir J 40:345–55.
- Vestbo J, Hurd SS, Agusti AG, et al. (2013). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 187:347–65.
- Viant MR. (2003). Improved methods for the acquisition and interpretation of NMR metabolomic data. Biochem Bioph Res Commun 310:943–8.
- Whillier S, Garcia B, Chapman BE, et al. (2011). Glutamine and α-ketoglutarate as glutamate sources for glutathione synthesis in human erythrocytes. FEBS J 278:3152–63.
- Xia J, Mandal R, Sinelnikov IV, et al. (2012). MetaboAnalyst 2.0-a comprehensive server for metabolomic data analysis. Nucleic Acids Res 40:W127–W33.
- Xia J, Broadhurst DI, Wilson M, Wishart DS. (2013). Translational biomarker discovery in clinical metabolomics: an introductory tutorial. Metabolomics 9:280–99.
- Xue H, Field C. (2010). New role of glutamate as an immunoregulator via glutamate receptors and transporters. Front Biosci (Schol Ed) 3:1007–20.